Literature DB >> 9774576

Rapid identification of Candida species with species-specific DNA probes.

C M Elie1, T J Lott, E Reiss, C J Morrison.   

Abstract

Rapid identification of Candida species has become more important because of an increase in infections caused by species other than Candida albicans, including species innately resistant to azole antifungal drugs. We previously developed a PCR assay with an enzyme immunoassay (EIA) format to detect amplicons from the five most common Candida species by using universal fungal primers and species-specific probes directed to the ITS2 region of the gene for rRNA. We designed probes to detect seven additional Candida species (C. guilliermondii, C. kefyr, C. lambica, C. lusitaniae, C. pelliculosa, C. rugosa, and C. zeylanoides) included in the API 20C sugar assimilation panel, five probes for species not identified by API 20C (C. haemulonii, C. norvegica, C. norvegensis, C. utilis, and C. viswanathii), and a probe for the newly described species C. dubliniensis, creating a panel of 18 Candida species probes. The PCR-EIA correctly identified multiple strains of each species tested, including five identified as C. albicans by the currently available API 20C database but determined to be C. dubliniensis by genotypic and nonroutine phenotypic characteristics. Species identification time was reduced from a mean of 3.5 days by conventional identification methods to 7 h by the PCR-EIA. This method is simple, rapid, and feasible for identifying Candida species in clinical laboratories that utilize molecular identification techniques and provides a novel method to differentiate the new species, C. dubliniensis, from C. albicans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774576      PMCID: PMC105312     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

Review 2.  Epidemiology of nosocomial fungal infections, with emphasis on Candida species.

Authors:  W R Jarvis
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

3.  Nosocomial candidemia: risk factors and attributable mortality.

Authors:  R P Wenzel
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

4.  Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species.

Authors:  T J Lott; R J Kuykendall; E Reiss
Journal:  Yeast       Date:  1993-11       Impact factor: 3.239

5.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

6.  Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.

Authors:  J H Rex; M A Pfaller; A L Barry; P W Nelson; C D Webb
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 7.  Importance of Candida species other than C. albicans as pathogens in oncology patients.

Authors:  J R Wingard
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

8.  Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy.

Authors:  J D Sobel; J Vazquez; M Lynch; C Meriwether; M J Zervos
Journal:  Clin Infect Dis       Date:  1993-01       Impact factor: 9.079

9.  Three distinct genotypes within Candida parapsilosis from clinical sources.

Authors:  D Lin; L C Wu; M G Rinaldi; P F Lehmann
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

10.  Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood.

Authors:  S Fujita; B A Lasker; T J Lott; E Reiss; C J Morrison
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

View more
  48 in total

1.  Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes.

Authors:  Y C Chen; J D Eisner; M M Kattar; S L Rassoulian-Barrett; K LaFe; S L Yarfitz; A P Limaye; B T Cookson
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Emerging Issues in Nosocomial Fungal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

3.  Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections.

Authors:  J Xu; B C Millar; J E Moore; R McClurg; M J Walker; J Evans; S Hedderwick; R McMullan
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

Review 4.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

5.  Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies.

Authors:  Agnes Marot-Leblond; Bertrand Beucher; Sandrine David; Sandrine Nail-Billaud; Raymond Robert
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

6.  Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.

Authors:  Annemarie Borst; Maria T Raimer; David W Warnock; Christine J Morrison; Beth A Arthington-Skaggs
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

7.  Evidence for a pseudo-outbreak of Candida guilliermondii fungemia in a university hospital in Brazil.

Authors:  Eduardo Alexandrino Servolo Medeiros; Timothy J Lott; Arnaldo Lopes Colombo; Patrício Godoy; Ana Paula Coutinho; Monica Santos Braga; Marcio Nucci; Mary E Brandt
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

8.  Rapid identification of candida species by TaqMan PCR.

Authors:  M Guiver; K Levi; B A Oppenheim
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

9.  Candida dubliniensis at a university hospital in Saudi Arabia.

Authors:  R Fotedar; S S A Al-Hedaithy
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.

Authors:  Rana A Hajjeh; Andre N Sofair; Lee H Harrison; G Marshall Lyon; Beth A Arthington-Skaggs; Sara A Mirza; Maureen Phelan; Juliette Morgan; Wendy Lee-Yang; Meral A Ciblak; Lynette E Benjamin; Laurie Thomson Sanza; Sharon Huie; Siew Fah Yeo; Mary E Brandt; David W Warnock
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.